Yansambou Mahamadou Seyni, Diallo Alpha Amadou, Idi Moumouni, Gagara Haladou, Haido Abdoul Malick, Bada Alambedji Rianatou
Laboratoire Central de l'Elevage (LABOCEL), Niamey, Niger.
Laboratoire National de l'Elevage et de Recherches Vétérinaires (LNERV), Dakar, Senegal.
Front Vet Sci. 2018 Oct 12;5:238. doi: 10.3389/fvets.2018.00238. eCollection 2018.
Contagious bovine pleuropneumonia (CBPP) is a highly contagious disease of cattle caused by subsp. Biotype Small Colony (MmmSC). The disease currently occurs in most of sub-Saharan Africa and where it is endemic and a major constraint for improving pastoral productivity. Following the persistence of this scourge, and in order to control this disease, a serological survey was conducted to determine the prevalence of CBPP in Niger. In fact, 1,590 sera were collected following a stratified sampling plan based on the risk factor of dissemination of CBPP. The analysis were performed at the Central Livestock Laboratory using the c-Elisa test. The results obtained show a wide distribution of the disease with an overall prevalence of 4.15% at individual level. The highest prevalences were recorded in the South-East regions [Zinder (7.5%), Diffa (7.5%)] and the West part [Tahoua (6.9%)]. The prevalence at the commune level was about 36.55%, which was relatively high. The prevalence at strata level was 36.55% (95% PI 0.2428-0.4882). The expected prevalences did not match those found. The results of this serological survey are considered the reference situation (T0) of CBPP in Niger with the PRAPS project, and allowed to the country to redefine control policies for better control of the disease at national and sub-regional level.
牛传染性胸膜肺炎(CBPP)是由生物型小菌落亚种(MmmSC)引起的牛的一种高度传染性疾病。该病目前在撒哈拉以南非洲的大部分地区流行,是这些地区的地方病,也是提高畜牧业生产力的主要制约因素。在这种祸害持续存在之后,为了控制这种疾病,在尼日尔进行了一项血清学调查,以确定CBPP的流行情况。事实上,根据CBPP传播的风险因素,按照分层抽样计划收集了1590份血清样本。检测分析在中央畜牧实验室采用c - ELISA试验进行。所获得的结果表明该病分布广泛,个体水平的总体流行率为4.15%。东南部地区[津德尔(7.5%)、迪法(7.5%)]和西部地区[塔胡阿(6.9%)]的流行率最高。公社层面的流行率约为36.55%,相对较高。各层的流行率为36.55%(95%预测区间0.2428 - 0.4882)。预期流行率与实际发现的情况不符。这次血清学调查的结果被视为尼日尔在PRAPS项目下CBPP的参考情况(T0),并使该国能够重新制定控制政策,以便在国家和次区域层面更好地控制该疾病。